Company: LRHC
Filing Date: 2025-07-17
Form Type: 424B3
Source: 0001213900-25-065175
Chunk: 36

Company: La Rosa Holdings Corp.
Filing Date: 2025-07-17
Form: 424B3
Chunk 36
---
 shares of common stock or any other securities that are at any time convertible into, or exercisable or exchangeable for, or otherwise
entitle the holder thereof to receive, common stock, at an effective price per share less than the Conversion Price of the Series B Preferred
Stock then in effect, the Conversion Price of the Series B Preferred Stock will be reduced to equal the effective price per share in
such dilutive issuance.

Company Optional Redemption Rights

Under the Certificate of Designation, the
Company has the right to redeem all, but not less than all, of the then outstanding shares of Series B Preferred Stock at a price equal
to the greater of (i) the Conversion Amount being redeemed and (ii) the product of (1) the Conversion Rate with respect to the Conversion
Amount being redeemed multiplied by (2) the greatest Closing Sale Price (as defined therein) of the common stock on any trading day during
the period commencing on the date immediately preceding the date of the Company’s notice to the holder(s) of Series B Preferred
Stock of such redemption and ending on the trading day immediately prior to the date the Company makes the entire redemption payment
required to be made under the Certificate of Designation.

Registration Rights Agreement

The Company also entered into a registration
rights agreement with the Selling Stockholder (the “Registration Rights Agreement”) with respect to the resale of the shares
of common stock issuable upon conversion of the Initial Note (the “Conversion Shares”) and Incremental Notes (the “Incremental
Conversion Shares”). The Registration Rights Agreement requires that the Conversion Shares and Incremental Conversion Shares be
registered by the Company under the Securities Act of 1933, as amended, by no later than the 90th calendar day after the Closing Date
(or, if the relevant registration statement is subject to a full review by the SEC, 120th calendar day after the Closing Date).

As we reported on a Form 8-K filed with the SEC
on May 28, 2025, on May 23, 2025, the Company and the Selling Stockholder entered into that certain waiver agreement (the “Waiver”),
dated May 23, 2025, pursuant to which the Selling Stockholder waived a provision of the Registration Rights Agreement to register for
resale the shares of common stock issuable upon conversion of the Incremental Notes, in the registration statement which this prospectus
forms a part, and all related rights to receive any Registration Delay Payments (as defined in the